Apeloa Pharmaceutical Co Ltd (000739) — Cash Flow Reinvestment Rate
Apeloa Pharmaceutical Co Ltd (000739) has a Cash Flow Reinvestment Rate of 0.38x as of December 2025, reinvesting CN¥168.67 Million (capex CN¥166.73 Million plus investments CN¥1.94 Million) from operating cash flow of CN¥446.18 Million. Check how high is Apeloa Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Apeloa Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Apeloa Pharmaceutical Co Ltd across 26 annual periods. Explore 000739 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Apeloa Pharmaceutical Co Ltd (1998–2025)
Year-by-year capital reinvestment analysis for Apeloa Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Apeloa Pharmaceutical Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.35x | CN¥435.36 Million | CN¥1.23 Billion | CN¥386.21 Million | ▼ -17.0% |
| 2024 | 0.43x | CN¥515.11 Million | CN¥1.21 Billion | CN¥460.75 Million | ▼ -66.4% |
| 2023 | 1.27x | CN¥1.31 Billion | CN¥1.03 Billion | CN¥630.47 Million | ▲ +226.5% |
| 2022 | 0.39x | CN¥514.89 Million | CN¥1.33 Billion | CN¥509.11 Million | ▼ -70.1% |
| 2021 | 1.30x | CN¥794.48 Million | CN¥611.75 Million | CN¥701.92 Million | ▲ +96.6% |
| 2020 | 0.66x | CN¥699.74 Million | CN¥1.06 Billion | CN¥317.12 Million | ▲ +130.1% |
| 2019 | 0.29x | CN¥390.45 Million | CN¥1.36 Billion | CN¥31.85 Million | ▲ +30.6% |
| 2018 | 0.22x | CN¥183.02 Million | CN¥832.69 Million | CN¥81.62 Million | ▼ -82.6% |
| 2017 | 1.26x | CN¥264.82 Million | CN¥209.80 Million | CN¥163.42 Million | ▼ -63.9% |
| 2016 | 3.50x | CN¥631.12 Million | CN¥180.42 Million | CN¥331.35 Million | ▲ +240.8% |
| 2015 | 1.03x | CN¥452.75 Million | CN¥441.16 Million | CN¥452.06 Million | ▲ +49.4% |
| 2014 | 0.69x | CN¥540.22 Million | CN¥786.64 Million | CN¥540.22 Million | ▼ -74.1% |
| 2013 | 2.65x | CN¥505.01 Million | CN¥190.45 Million | CN¥505.01 Million | ▲ +162.3% |
| 2012 | 1.01x | CN¥339.59 Million | CN¥335.90 Million | CN¥339.59 Million | ▲ +41.4% |
| 2011 | 0.71x | CN¥289.21 Million | CN¥404.62 Million | CN¥289.21 Million | ▼ -38.1% |
| 2010 | 1.15x | CN¥139.81 Million | CN¥121.05 Million | CN¥139.81 Million | ▲ +156.9% |
| 2009 | 0.45x | CN¥93.66 Million | CN¥208.30 Million | CN¥93.66 Million | ▼ -87.8% |
| 2008 | 3.69x | CN¥349.04 Million | CN¥94.57 Million | CN¥349.04 Million | ▲ +455.7% |
| 2007 | 0.66x | CN¥115.70 Million | CN¥174.20 Million | CN¥115.70 Million | ▲ +96.7% |
| 2006 | 0.34x | CN¥53.84 Million | CN¥159.43 Million | CN¥53.84 Million | ▼ -75.7% |
| 2005 | 1.39x | CN¥121.65 Million | CN¥87.40 Million | CN¥121.65 Million | ▼ -40.4% |
| 2004 | 2.34x | CN¥111.07 Million | CN¥47.54 Million | CN¥111.07 Million | ▲ +179.4% |
| 2003 | 0.84x | CN¥88.09 Million | CN¥105.36 Million | CN¥88.09 Million | ▼ -95.0% |
| 2002 | 16.78x | CN¥47.23 Million | CN¥2.81 Million | CN¥47.23 Million | ▲ +3595.5% |
| 2000 | 0.45x | CN¥3.22 Million | CN¥7.08 Million | CN¥3.22 Million | ▼ -16.8% |
| 1998 | 0.55x | CN¥16.43 Million | CN¥30.10 Million | CN¥16.43 Million | — |